Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly)
Bhargava, H.N.; Ramarao, P.
Progress in Clinical and Biological Research 328: 493-496
1990
ISSN/ISBN: 0361-7742 PMID: 2154810 Document Number: 362725
Document emailed within 1 workday
Related Documents
Horan, P.; de Costa, B.R.; Rice, K.C.; Porreca, F. 1991: Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice Journal of Pharmacology and Experimental Therapeutics 257(3): 1154-1161Sheldon, R.J.; Porreca, F. 1987: Mu receptor mediated inhibition of rat urinary bladder motility: differential antagonism by kappa agonists Proceedings of the Western Pharmacology Society 30: 357-360
Kamei, J.; Iwamoto, Y.; Misawa, M.; Nagase, H.; Kasuya, Y. 1994: Antitussive effect of (+/-) pentazocine in diabetic mice is mediated by delta-sites, but not by mu- or kappa-opioid receptors Nihon Shinkei Seishin Yakurigaku Zasshi 14(3): 147-152
Baraban, S.C.; Lothman, E.W.; Lee, A.; Guyenet, P.G. 1995: Kappa opioid receptor-mediated suppression of voltage-activated potassium current in a catecholaminergic neuronal cell line Journal of Pharmacology and Experimental Therapeutics 273(2): 927-933
Slizgi, G.R.; Taylor, C.J.; Ludens, J.H. 1984: Effects of the highly selective kappa opioid, U-50, 488, on renal function in the anesthetized dog Journal of Pharmacology and Experimental Therapeutics 230(3): 641-645
Hall, E.D.; Wolf, D.L.; McCall, R.B. 1988: Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate Circulatory Shock 26(4): 409-417
Mukhin, V.N.; Abdurasulova, I.N.; Pavlov, K.I.; Klimenko, V.M. 2015: Effects of activation of kappa-opioid receptors on the behavior at the postnatal development of the stress reactivity systems Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 101(3): 268-278
Guirimand, F.; Strimbu-Gozariu, M.; Willer, J.C.; Le Bars, D. 1994: Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat Journal of Pharmacology and Experimental Therapeutics 269(3): 1007-1020
Negus, S.S.; Henriksen, S.J.; Mattox, A.; Pasternak, G.W.; Portoghese, P.S.; Takemori, A.E.; Weinger, M.B.; Koob, G.F. 1993: Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats Journal of Pharmacology and Experimental Therapeutics 265(3): 1245-1252
Barbaz, B.S.; Autry, W.L.; Ambrose, F.G.; Gerber, R.; Liebman, J.M. 1985: Differential antagonism by proglumide of various CCK-mediated effects in mice Progress in Clinical and Biological Research 192: 151-158
Staessen, J.; Fiocchi, R.; Fagard, R.; Lijnen, P.; Amery, A. 1986: Alpha-adrenoceptor blockade by tibalosine: hemodynamic and humoral effects at rest and during exercise, and effect of opioid receptor antagonism Journal of Cardiovascular Pharmacology 8(5): 1028-1034
Verberne, A.J.; Louis, W.J. 1989: Interaction between the cardiovascular effects of clonidine and the kappa-opioid agonist U-50,488H in the anterior hypothalamic area of the rat brain Journal of Pharmacy and Pharmacology 41(2): 131-133
Altenberg, G.A.; Subramanyam, M.; Reuss, L. 1994: Muscarinic stimulation of gallbladder epithelium. III. Antagonism of cAMP-mediated effects American Journal of Physiology 267(5 Pt 1): C1196-C1202
Franzoso, G.; Bours, V.; Azarenko, V.; Park, S.; Tomita-Yamaguchi, M.; Kanno, T.; Brown, K.; Siebenlist, U. 1993: The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites EMBO Journal 12(10): 3893-3901
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Picker, M.J.; Doty, P.; Negus, S.S.; Mattox, S.R.; Dykstra, L.A. 1990: Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists Journal of Pharmacology and Experimental Therapeutics 254(1): 13-22
von Bülow, V.; Dubben, S.; Engelhardt, G.; Hebel, S.; Plümäkers, B.; Heine, H.; Rink, L.; Haase, H. 2007: Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B Journal of Immunology 179(6): 4180-4186
Hirose, Y.; Ogawa, N.; Mori, A. 1986: Reversible down-regulation of liver cyclo(His-Pro) binding sites by cyclo(His-Pro) administration to mice Research Communications in Chemical Pathology and Pharmacology 54(2): 211-216
Pechnick, R.; George, R.; Poland, R.E. 1985: Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3 Journal of Pharmacology and Experimental Therapeutics 232(1): 170-177
Devlin, T.; Shoemaker, W.J. 1990: Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain Journal of Pharmacology and Experimental Therapeutics 253(2): 749-759